Home » Topics » BioWorld Science

BioWorld Science
RSS

Academia and industry establish immune-mediated inflammatory diseases consortium

May 31, 2018

Kissei announces negative topline results from the additional phase III study of KPS-0373

May 31, 2018

ConSynance announces initiation of toxicology studies of CSTI-300 for IBS-D

May 31, 2018

DSMB clears phase II trial of AG-013 for oral mucositis to continue

May 30, 2018

FDA grants priority review to Sage's NDA for intravenous brexanolone for postpartum depression

May 30, 2018

Atox initiates phase II trial of reltecimod in acute kidney injury

May 30, 2018

FDA approves Imvexxy to treat moderate to severe dyspareunia due to menopause

May 30, 2018

Nur77-deficient mice show altered dendritic cell functioning

May 30, 2018

Antitumor efficacy seen with HERA-GITRL fusion protein from Apogenix

May 30, 2018

miR-126 and miR-223 found as potential biomarkers of cardiac sarcoidosis

May 30, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...